Target intelligence / Profile preview

Novel transcript, antisense to LCN6 (ENSG00000299551)

Target
ENSG00000299551
Molecular classification
Other (natural antisense transcript, long non-coding RNA)
01

Overview

Natural antisense transcripts are RNA molecules transcribed from the DNA strand opposite to a known gene, here opposite LCN6. These transcripts often do not code for proteins, but instead regulate their sense gene partners (such as LCN6) at the transcriptional or post-transcriptional level via mechanisms like transcriptional interference, RNA masking, RNA-RNA duplex formation (leading to RNA interference), and modulation of chromatin structure through recruitment of chromatin modifiers or alteration of DNA methylation[2][3][4]. While antisense RNAs are proposed to broadly regulate gene expression and sometimes participate in disease pathogenesis, “novel transcript, antisense to LCN6” itself is not a defined receptor, enzyme, or druggable target; its biological roles and clinical significance remain undemonstrated as of current knowledge[2][3][4].

Other names
Antisense to LCN6ENSG00000299551
02

Biological functions

Gene expression regulationEpigenetic modulation (potential)RNA interference mechanisms (potential)
03

Disease associations

Other (antisense RNAs have been implicated generically in epigenetic regulation and may sometimes contribute to disease processes by regulating gene expression, but there is no evidence tying this specific transcript to any disease[2][3])

Beyond the preview

Go deeper on Novel transcript, antisense to LCN6 (ENSG00000299551).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to LCN6 (ENSG00000299551).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call